Home > PS Ratio > BIOCON

BIOCON
PS (Price/Sales) Ratio

The Current P/S Ratio of BIOCON is 2.78.

Share Price ₹344.8Dec 24,2024
Market Cap ₹41,396.7 Cr
Sales-TTM₹14,894.1 CrTTM-Consolidated Results
Price/Sales2.78xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BIOCON

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BIOCON is calculated as :

Current Market Cap [ ₹41,396.7 Cr] as on Dec 24,2024

(/) Sales [ ₹14,894.1 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.78x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BIOCON , the investors are currently willing to pay '2.78 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BIOCON !

The chart below summarizes the trend in P/S Ratio of BIOCON over the last five years.

Historical PS (Price/Sales) ratio chart of BIOCON


PS Ratio Performance Analysis for BIOCON

- BIOCON 's latest p/e ratio is 2.78x.

- BIOCON 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.26x.

- BIOCON 's operated at median p/e ratio of 4.91x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BIOCON 's p/e ratio peaked in Mar2021 at 6.87x.

- BIOCON 's p/e ratio hit its five-year low in Mar2024 of 2.15x.


How does BIOCON 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BIOCON 14,894.12.7841,396.7
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.67436,103.0
CIPLA LTD26,512.04.50119,196.0
DR REDDYS LABORATORIES LTD30,084.93.75112,752.0
ZYDUS LIFESCIENCES LTD21,483.54.5297,041.2
DIVIS LABORATORIES LTD8,614.017.82153,540.0
MANKIND PHARMA LTD11,018.010.90120,073.0
TORRENT PHARMACEUTICALS LTD11,225.010.25115,112.0
LUPIN LTD21,431.34.6298,925.3
AUROBINDO PHARMA LTD30,295.02.4273,314.6
ABBOTT INDIA LTD6,066.19.9760,480.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BIOCON 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.42x
Max industry PS 17.82x
Median industry PS 4.62x
Average industry PS 7.29x



You may also like the below Video Courses